{"ticker": {"uuid": "e2634ccb-95a8-4ba0-a93e-a17ca9a0fe6e", "symbol": "ABSI", "name": "Absci Corp", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Absci (NASDAQ:ABSI) Stock Price Down 7.6% - Should You Sell?", "summary": "Absci (NASDAQ:ABSI) shares dropped 7.6% in mid-day trading following a period of mixed analyst sentiment, despite some analysts raising price targets and maintaining buy ratings. The company's recent earnings report showed better-than-expected EPS but significantly missed revenue", "url": "https://www.marketbeat.com/instant-alerts/absci-nasdaqabsi-stock-price-down-76-should-you-sell-2026-07-16/", "source_name": "MarketBeat", "published_at": "2026-07-16T16:41:35", "published_display": "16 Jul 2026 16:41", "sentiment": "negative", "sentiment_pct": 39, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci to Report Business Updates and Second Quarter 2026 Financial and Operating Results on August 11, 2026", "summary": "Absci Corporation, a clinical-stage biopharmaceutical company, announced it will report business updates and financial results for the second quarter of 2026 after market close on Tuesday, August 11, 2026. A conference call and webcast will follow the announcement to discuss deve", "url": "https://www.globenewswire.com/news-release/2026/07/14/3327246/0/en/absci-to-report-business-updates-and-second-quarter-2026-financial-and-operating-results-on-august-11-2026.html", "source_name": "GlobeNewswire", "published_at": "2026-07-15T14:10:35", "published_display": "15 Jul 2026 14:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci to report Q2FY26 results on August 11, 2026", "summary": "Absci Corporation will release its Q2FY26 financial results and host a conference call on August 11, 2026, to discuss its business updates, financial performance, and future outlook. The clinical-stage biopharmaceutical company, which utilizes generative AI for drug design, is ad", "url": "https://scanx.trade/stock-market-news/companies/absci-to-report-q2fy26-results-on-august-11-2026/45615232", "source_name": "scanx.trade", "published_at": "2026-07-14T23:12:06", "published_display": "14 Jul 2026 23:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci sets 4:30 p.m. ET webcast for its Aug. 11 Q2 update", "summary": "Absci (Nasdaq: ABSI) will report its second quarter 2026 financial and operating results on Tuesday, August 11, 2026, after market close. Management will host a webcasted conference call at 4:30 p.m. Eastern Time to discuss business developments, financial performance, and outloo", "url": "https://www.stocktitan.net/news/ABSI/absci-to-report-business-updates-and-second-quarter-2026-financial-s1qokclg0o80.html", "source_name": "Stock Titan", "published_at": "2026-07-14T20:12:06", "published_display": "14 Jul 2026 20:12", "sentiment": "positive", "sentiment_pct": 59, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wall Street Analysts Predict a 28.3% Upside in ABSCI CORP (ABSI): Here's What You Should Know", "summary": "Wall Street analysts predict a 28.3% upside for Absci Corporation (ABSI), with an average price target of $13.6 and a standard deviation indicating general agreement. While price targets alone are not a reliable investment guide due to potential optimism and business incentives, ", "url": "https://finance.yahoo.com/markets/stocks/articles/wall-street-analysts-predict-28-135502653.html", "source_name": "Market source", "published_at": "2026-07-14T01:16:29", "published_display": "14 Jul 2026 01:16", "sentiment": "positive", "sentiment_pct": 71, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Wall Street Zen Downgrades Absci (NASDAQ:ABSI) to Sell", "summary": "Wall Street Zen downgraded Absci (NASDAQ:ABSI) from a \"hold\" to a \"sell\" rating, despite several other analysts recently raising their price targets and maintaining \"buy\" ratings, leading to an overall \"Moderate Buy\" consensus. The downgrade followed Absci's quarterly results, wh", "url": "https://www.marketbeat.com/instant-alerts/wall-street-zen-downgrades-absci-nasdaqabsi-to-sell-2026-07-12/", "source_name": "MarketBeat", "published_at": "2026-07-12T18:39:26", "published_display": "12 Jul 2026 18:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci (ABSI) Morgan Stanley 22nd Annual Global Healthcare Conference Summary", "summary": "Absci (ABSI) discussed its strategic transition from a platform technology company to an AI-driven drug creation firm at the Morgan Stanley 22nd Annual Global Healthcare Conference. The company is now focusing on developing a proprietary pipeline with generative AI for antibody d", "url": "https://quartr.com/events/absci-corporation-absi-morgan-stanley-22nd-annual-global-healthcare-conference_F9f2Jcso", "source_name": "Quartr", "published_at": "2026-07-08T23:39:59", "published_display": "08 Jul 2026 23:39", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci (ABSI) Morgan Stanley 23rd Annual Global Healthcare Conference Summary", "summary": "Absci highlighted its strategic focus on leveraging AI for generative design to tackle challenging drug targets, aiming to reduce development timelines and costs while advancing novel biology. The company discussed its pipeline, including ABS-101 and ABS-201, with key clinical re", "url": "https://quartr.com/events/absci-corporation-absi-morgan-stanley-23rd-annual-global-healthcare-conference_F9f2viKS", "source_name": "Quartr", "published_at": "2026-07-08T11:39:12", "published_display": "08 Jul 2026 11:39", "sentiment": "positive", "sentiment_pct": 77, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci (ABSI) Q4 2024 earnings summary", "summary": "Absci (ABSI) made significant progress in 2024, advancing internal programs and securing new partnerships. Financially, Q4 2024 revenue was $0.7 million, with a full-year revenue of $4.5 million, and the company ended the year with $112.4 million in cash, expected to fund operati", "url": "https://quartr.com/events/absci-corporation-absi-q4-2024_F9f2JrRP", "source_name": "Quartr", "published_at": "2026-07-08T11:39:12", "published_display": "08 Jul 2026 11:39", "sentiment": "positive", "sentiment_pct": 65, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci director Mary T Szela buys $148,866 in stock By Investing.com", "summary": "Absci Corp director Mary T Szela recently purchased 12,900 shares of company common stock for $148,866. This transaction increased her direct ownership to 21,300 shares, occurring while the stock trades near its 52-week high and has seen a 319% return. The company is also advanci", "url": "https://ng.investing.com/news/stock-market-news/absci-director-mary-t-szela-buys-148866-in-stock-93CH-2587530", "source_name": "Investing.com Nigeria", "published_at": "2026-07-07T11:40:29", "published_display": "07 Jul 2026 11:40", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Absci Corp For: 6 July By Investing.com", "summary": "This article from Investing.com reports on a Form 4 filing for Absci Corp (ABSI) dated July 6. The brief piece includes the company's stock symbol and a small negative percentage change for the day, indicating it's a routine financial filing announcement.", "url": "https://ng.investing.com/news/stock-market-news/form-4-absci-corp-for-6-july-93CH-2587542", "source_name": "Investing.com Nigeria", "published_at": "2026-07-07T11:11:07", "published_display": "07 Jul 2026 11:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "H.C. Wainwright Maintains Absci Corp(ABSI.US) With Buy Rating, Maintains Target Price $16", "summary": "H.C. Wainwright has reiterated its Buy rating for Absci Corp (ABSI.US) and maintained a target price of $16. This indicates the firm's continued confidence in the company's future performance.", "url": "https://www.moomoo.com/news/post/72526540/hc-wainwright-maintains-absci-corp-absius-with-buy-rating-maintains", "source_name": "Moomoo", "published_at": "2026-07-06T23:07:43", "published_display": "06 Jul 2026 23:07", "sentiment": "positive", "sentiment_pct": 72, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci (ABSI) director buys 12,900 shares in open-market trade", "summary": "Absci Corp. director Mary T. Szela purchased 12,900 shares of Common Stock at $11.54 per share on June 30, 2026, in an open-market transaction. This transaction increased her direct ownership to 21,300 shares, as detailed in the SEC Form 4 filing. The purchase was executed in acc", "url": "https://www.stocktitan.net/sec-filings/ABSI/form-4-absci-corp-insider-trading-activity-ffd736052e9a.html", "source_name": "Stock Titan", "published_at": "2026-07-06T19:40:25", "published_display": "06 Jul 2026 19:40", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci director Mary T Szela buys $148,866 in stock", "summary": "Absci Corp (NASDAQ:ABSI) director Mary T Szela purchased 12,900 shares of company common stock for $148,866 on June 30, 2026, increasing her direct ownership to 21,300 shares. This insider purchase comes as Absci trades near its 52-week high after a significant 319% return over t", "url": "https://www.investing.com/news/insider-trading-news/absci-director-mary-t-szela-buys-148866-in-stock-93CH-4777404", "source_name": "Investing.com", "published_at": "2026-07-06T16:18:00", "published_display": "06 Jul 2026 16:18", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Absci (ABSI) Undervalued On Encouraging ABS 201 Phase 1 Data?", "summary": "Absci (ABSI) is experiencing strong short-term momentum with its stock up over 221% year-to-date, driven by encouraging interim Phase 1 data for its investigational drug ABS-201 and a recent US$100 million equity offering. While one narrative suggests the company is 6.3% underval", "url": "https://www.sahmcapital.com/news/content/is-absci-absi-undervalued-on-encouraging-abs-201-phase-1-data-2026-07-05", "source_name": "Sahm", "published_at": "2026-07-05T23:10:09", "published_display": "05 Jul 2026 23:10", "sentiment": "positive", "sentiment_pct": 65, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Absci Corporation \u2013 NASDAQ:ABSI", "summary": "This article provides the enterprise value to revenue (forward) for Absci Corporation (NASDAQ: ABSI). It specifies the period, the value, and the percentage change for this financial metric. The information is presented by TradingView, sourcing data from ICE Data Services and Fac", "url": "https://www.tradingview.com/symbols/NASDAQ-ABSI/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-03T11:40:25", "published_display": "03 Jul 2026 11:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Truist Financial Maintains Absci Corp(ABSI.US) With Buy Rating, Raises Target Price to $17", "summary": "Truist Financial has reiterated its \"Buy\" rating for Absci Corp (ABSI.US) and increased its target price to $17. This indicates a positive outlook from the financial institution regarding Absci's stock performance.", "url": "https://news.futunn.com/en/post/75459186/truist-financial-maintains-absci-corp-absius-with-buy-rating-raises", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-07-03T09:40:25", "published_display": "03 Jul 2026 09:40", "sentiment": "positive", "sentiment_pct": 73, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Absci Corporation \u2013 NASDAQ:ABSI", "summary": "This article provides a view of Absci Corporation's (NASDAQ: ABSI) financial data, specifically focusing on its forward price-to-sales ratio. It briefly lists essential financial and market information available on TradingView for the company. The content appears to be a stub or ", "url": "https://www.tradingview.com/symbols/NASDAQ-ABSI/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-03T04:10:41", "published_display": "03 Jul 2026 04:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BTIG Maintains Absci Corp(ABSI.US) With Buy Rating, Maintains Target Price $13", "summary": "BTIG has reiterated its Buy rating for Absci Corp (ABSI.US) and maintained its target price at $13. This indicates a continued positive outlook from the analyst firm regarding the company's stock performance.", "url": "https://news.futunn.com/en/post/75392556/btig-maintains-absci-corp-absius-with-buy-rating-maintains-target", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-07-03T01:10:41", "published_display": "03 Jul 2026 01:10", "sentiment": "positive", "sentiment_pct": 77, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ABSI Maintained by Truist Securities -- Price Target Raised to $17.00", "summary": "Truist Securities has maintained a Buy rating for Absci (ABSI) and increased its price target from $11.00 to $17.00, indicating a bullish outlook. Despite this, GuruFocus assesses ABSI as significantly overvalued by 527.4% with a GF Value of $1.77 against its current price of $11", "url": "https://www.gurufocus.com/news/8943086/absi-maintained-by-truist-securities-price-target-raised-to-1700?mobile=true%3Fmobile%3Dtrue", "source_name": "GuruFocus", "published_at": "2026-07-02T18:09:26", "published_display": "02 Jul 2026 18:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci (ABSI) Is Up 10.3% After Positive ABS-201 Phase 1 Data And $100M Equity Raise", "summary": "Absci Corporation's stock (ABSI) rose 10.3% following positive interim Phase 1 data for its ABS-201 drug, which targets androgenetic alopecia, demonstrating favorable safety and a long half-life. Concurrently, the company completed a $100 million equity offering, providing capita", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-absi/absci/news/absci-absi-is-up-103-after-positive-abs-201-phase-1-data-and", "source_name": "Simply Wall Street", "published_at": "2026-07-02T14:09:26", "published_display": "02 Jul 2026 14:09", "sentiment": "positive", "sentiment_pct": 76, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why Absci Corporation (ABSI) is a Great Momentum Stock to Buy", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNb0RMbTZIa2pneFdnRGNDRWZ5dW1NRWItODZucm5acHo4VkVhT0UxNmlLQzZPTmxqbXB4UnowejBvZEVmWGp2X0J1RmZBNDFqY1VQdzEtLWFPeUlWSnBJQlI1c0RfQmRsTWRNRjVQYlZUY1JwR0lvb3h4UmM2dktsMWlFSHJxS3phZUdGM1NVYzFncWpiYUppcWRUMVNhdw?oc=5", "source_name": "Market source", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Absci Corporation \u2013 NASDAQ:ABSI", "summary": "This article provides access to the enterprise value to EBITDA forward metric for Absci Corporation (NASDAQ:ABSI) through TradingView. It indicates that the market for ABSI was closed at the time of viewing, with no trades mentioned. The content primarily focuses on navigation an", "url": "https://www.tradingview.com/symbols/NASDAQ-ABSI/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-07-01T17:39:59", "published_display": "01 Jul 2026 17:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Absci Corporation \u2013 NASDAQ:ABSI", "summary": "This article provides price-to-earnings forward data for Absci Corporation (NASDAQ: ABSI). It presents a table showing the period, value, and change percentage for this financial metric. The content is hosted on TradingView, indicating that it is a financial data point for invest", "url": "https://www.tradingview.com/symbols/NASDAQ-ABSI/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-30T20:10:42", "published_display": "30 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci Corporation Actuals & Estimates (NASDAQ:ABSI)", "summary": "This article provides an overview of Absci Corporation (NASDAQ: ABSI) stock performance, financial actuals, and analyst estimates. It highlights recent stock price movements, market capitalization, future price forecasts, and key financial metrics including earnings, revenue, and", "url": "https://www.tradingview.com/symbols/NASDAQ-ABSI/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-29T17:09:36", "published_display": "29 Jun 2026 17:09", "sentiment": "positive", "sentiment_pct": 71, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci Stock (ABSI) Opinions on Positive Phase 1 Data for ABS-201", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOdl82ZUl1UkRWUTNPQnNIZlZTY2FPWWtSVEVUazB3STdIMGlRdnF6bHotejVDZTVjMUJDY0s2TG1HeUFWM0ZORGlhdnVINWR0MG4tZUpyV2dhRDcyYWswZFBSMGoyMTF4cXRrTHJYeEx1NjIyRnpheFFieTFBeXNLS3dybEQ4Y1E4VFR5R3NOenpfSTN5MEl6U3dib1M?oc=5", "source_name": "Moomoo", "published_at": "2026-06-28T17:32:53+00:00", "published_display": "28 Jun 2026 17:32", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci Raises $100 Million In Equity To Fund AI-Designed Hair Loss And Endometriosis Program", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/absci-raises-100-million-equity-100125058.html", "source_name": "Benzinga", "published_at": "2026-06-27T10:01:25+00:00", "published_display": "27 Jun 2026 10:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lilly-backed Absci banks $100m to progress endometriosis, hair loss therapy", "summary": "", "url": "https://finance.yahoo.com/m/b1b53458-aba2-319a-9580-7855461fcb65/lilly-backed-absci-banks.html", "source_name": "Pharmaceutical Technology", "published_at": "2026-06-26T10:27:16+00:00", "published_display": "26 Jun 2026 10:27", "sentiment": "negative", "sentiment_pct": 42, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci (ABSI) Is Up 37.8% After ABS-201 Data And Equity Raise - Has The Bull Case Changed?", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/absci-absi-37-8-abs-080654598.html", "source_name": "Simply Wall St.", "published_at": "2026-06-26T08:06:54+00:00", "published_display": "26 Jun 2026 08:06", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ABSCI CORP (ABSI) Soars 36.0%: Is Further Upside Left in the Stock?", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxPQTA5VGNEQ1A2dXRvWVh0VGxadkx2eDV2bG9VeExQaFhuMzNwREFOcnhYRmZaQUEzQVRtbXZ1UHdFMUxBZFB5Tm1ra2RTbWZJTFduWjN6cTVDX2RqdWJ0RGRNSlM0RHZqTWRJNEM2Y1FGMlhxWEdCd2VITFR2dE90MTdIUk9CREc4OVhWbV8wSVpjd1E?oc=5", "source_name": "Market source", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "United States - Goodwin Guides Absci On Pricing Of $100 Million Underwritten Offering", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNbF8wWkY2OGV5aGRnT2t1V2xuN1BhUjFIc0ZybHZHNl96amdnblVLSl9Jdy1falpBOUZJaWJ2eXJMaWJxR1BKeGdHTGxzN3FiMnFUNm5YZU52S3JCQ0NXcW5rS2RRdFBfSE5FNGFtWFJjSHNjUm9qWmNFLW00RkFCdkRKTTIzVEc1azhXc2JqQV9jRGdVQWJhNTRuZkM3TDAxM19KcE1DQ1NlWmVnU2JKTV9IZ2U?oc=5", "source_name": "Mondaq", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci raises $100M as Lilly joins investors backing AI drug program", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxOZmhkb2tPNFpfS0x1QU1wUnl1eWNhMUhBcHpQV2lSVDNvb0RqZkVCTjBzZ3k5Wnc0MG45ZG0zTmFwbHBFS2ZtblFUblBvMkxiSmE3SWQ3Wjdha1YtWXhGMGY1V1h5amdnNGZiRzd3TlJLRHJ0bHJ2SWxfa3hKUlBYRGkwU1lZWkhBTXI3b0FkZkg4bDRIelRzMmNCRC1lV1BMRGdld0pPVXlSMHNUYlBCRjBIYnRiMFpLNEJwVw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci, FuelCell Energy surge premarket; Cerebras, FedEx tumble", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxPMk1rWWFqSnQycTNvQjZmTVBJR0RXZHFEdGhCUWJjN1ZuQlVnSDVWSkxfWG9CeWNiOHMxblFkU0dtWS1vYURPd3B5WTFMWHF5a19xVXhMOE55WEVCSEpZX0Z1Ym9raTdfZXZMOFU4RVlMOUNpZl91UWVvVzBld0I3cW9ZUVJmNVBpMlRKT3NFLV9ucWxhSnNLY2lZY0lkNEtwYWRUUVk0aURqTFdKVklVdWdMcmg4Zkk?oc=5", "source_name": "Investing.com", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci (ABSI) Stock Rallies As Wall Street Boosts Targets", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTFBfRS1uanRBYU9PREw5TjFmQjFIMDZhX1Z3aHJZYlFfbzFyVHBaVDNacXZRTlFIVkdMZEthRm5pczc2QkZhWlAyT2h0d08xUUxGVEJkaUxCODBfMG1aVlM0TkVIelFKRDJJS3NHd1JZSURoRXdqT2RReQ?oc=5", "source_name": "timothysykes.com", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci (NASDAQ: ABSI) prices $100M underwritten equity deal to fund ABS-201", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxQanBZOUJRaF9fZUxhN2JLTTE3dVZyOE5yNmdzek1FSm1fYV9OQUJGcUxtSlRkSlB2UVNzNFhsMHVBNDQxYU1Pb253M1lEaGNvWk02b2syRDktUXJvd1ZZZ2x0YzFrYWJQX3NobjljVFF5M1NVRHFjY1BXT084T1NHeTlpb0U4TFJRQVFiU2JEWTZValFzWDYxbVBWLWg2eXgy?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 424B5 Absci Corp For: 24 June By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxOY3RmdGJfbXZiZkhpS09GQUNlUEZJOUpVRmF2bTlTRmlKSEtOcTVlV3hJRVBMY0JDbVhlOWN2XzJJOS1VS3lZRlRDM3RVbHFUVHV4bzRlUWtvWkVVbXhzX0lpWklyV3QySmc0VVYzV0lYcmo5TmNxVmJMQUdEc2g3QVRKdlpwTjBBSGdqRjQwRVRYVjdSUTRMaGJn?oc=5", "source_name": "Investing.com Canada", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci\u2019s ABS-201 shows 65-day half-life in alopecia trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxNbkNRRWtkN3Y5Y3BWZGh5NGZjZzA2eFJlSHMwR09JLUhiLS1ZcEtzLTZ0U1JURG9YQ0dzcWFTa1E5M3VOc1V6V2l1N3BMY3R4YkMwOUpvcHgyVGttY3NrRkxhUUJYTkdvTHBYWlJ4TmVSQjBjOUVGSF84MG1LQVRtbFJUYTJST3JSSm5SZjJjVDNvd25aQUVqX05paVRYVjRuTzkwNFVPVUpyZDlVR3dIc0IwZ2R1MGI0azN3Rg?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci Shares Soar After Positive Early Clinical Results for Hair Loss Therapy (ABSI)", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNZDRiX1R1V04wSkNRaFUyc19lM2VmN2FrS0JPV1dwWnZkSlBCc1R5Q2hNSXRUWXQ4ZFk5VXR0Q2s4MURYanN2dERZTHVsOWIta1E5VEVJZHhjQkQ4cWFIaURlQ1JxRTRjRHZzZi13cDFnZXVPTS1BaWhWTVBqUFBSZUhQUlFMMi1lb2V0SThXUk9GVWJMT0JMbw?oc=5", "source_name": "Market source", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci rises after early-stage trial data for hair loss therapy and $100M stock offering", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxOczRlX3prd1EwTmYyR0JtY0g3TXhDUHpFUUp2VFlOT1NxMGt3SW5zdXdKb0FHbkVyZkFsNlZ4VHB3ektQc1ZjTFBsUFFnZzNqelFHRWZ2T2JfdkhRWS1YUm5yQnJxdzl0bXhyUWNEandmdmtSV1lfU3ZOUEVDeF9GRGJyZXhNOEQ5eXBHXy1HNzF1OHc?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guggenheim is Bullish on Absci Corporation (ABSI)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxOLUVHcXhrRFNWY2poS2pobnlzeHhTdmNWVUYzTzRoNGhGd1Nuc2M5cy1aZ3RFczFTTEN2cUFmWFRucmZqZ09RbVJ4QnkwaUxrMmdVQktpU1Y4UjdIQlotYW1ual9mMUYxbUhOU0tWaEFUSUJOQXI2NXFLWHQzM2lmQjV5TFViNkRMY2x1ZUJRS0RmQjczTmRPdzdoMVFNc1NfdW9uTw?oc=5", "source_name": "Market source", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci Corp stock hits 52-week high at 8.18 USD", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxQSkRfckVsSUlXakNuU1FteFNWc2RIRzM0ZWxXMXQwck5aRnNWdUV1NFN3YlhLRW1qNnM1Y1RDbXA2MHl1SXl5YzJDUThSc0lRY2tvODgzSWswZVhPYzlTV181UGNXMGxwbFNmWGFfcElhdk5LeWc5RGNhX3VvaVE5LVBReFdRbDVPQ2RHQURlNDdNR0RxN3gtOTN0NnBLc25uZzQ0?oc=5", "source_name": "Investing.com", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Absci Corporation (ABSI) A Good Stock To Buy Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNU1p4bXRNWHFyUzFDM21IUy12TGVFTXNRdW5uR2huTHd2NG9kOWdYSkJYZk5CXzJqNFdHdEpqTW1PdHgwcHJnLWNmZ3h1c3ctbWNfZ2huYjh0ZnVFY1k2ZmdaZHF6alRsLVd3bjRkTklMcmlONGFZSXN1bHFJcXdRdGp1akRXNlphZTNqNjRsQnR3c1ZHNTQ5ZjE1bzQwaUU?oc=5", "source_name": "Market source", "published_at": "2026-06-21T07:00:00+00:00", "published_display": "21 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guggenheim raises Absci stock price target to $15 on hair loss drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNNlZEcjRBWUtabFUweW84dFdyY2Z2OHkxMHVyUW5hZUhrbFFJZUE2S0I2MnFOZVFnNTkxLTFHLXFXeURtbjlrTXM5UDk3N21sZ095bXNUa2xxQWJHV2ptbTFnMVlrWm9CWjNCWDN5a0E0V0NXYnJyZnhWcTZEODYtTGNTSENJMk1DSnNYc2J0SUl0aDVCZFNENC1sN1Y2V1N4OHJ2cTlFYVViMXVxRkE0UjFTcjV2UGZkR2NmdktxVWM5Rlcy?oc=5", "source_name": "Investing.com", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci Corp (ABSI) awards RSUs and stock options to director Szela", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOX1M1b2o3MnRTRXloUkEtcEQzX3Ezal8wTEN0N19nQTd1QldxVkVSZnV5V29xaExnTFdEMXFxMU5KSzkwTER3LUJFZ2hpdkYxVmVfRG5GV2c3WnpFS0FIVTd2OG0xODBPcDV2UWhucDlCV2RNZ1ZGT0p3MDFYUGJTbkV2SmhuWENVT2xOYWZFSmVYTnpSMDMyelg3WjJFaWtJRTQ1SFlOZmZfMWFoZFhyNm5zdjk?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci Corp stock hits 52-week high at 7.44 USD", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPbkdVa21lZWJaVk82My1IbDliT1J5QWN5dDZUUkZBUWFRa0ZEcjdQVmZ2cDJuc1czZVhYNjNmMEk2TlpSQkMyQlA4T010cGNIWWItSFp4cGVjQTMxZnFSZF9nNUVjWGNLclpOSHFvTjVxUkxIam1ObGozNkp6Y1NNVms3SU51MG1QR29rcEVOcUt1eDZGNkN2U242RFZLOTJtRWZz?oc=5", "source_name": "Investing.com", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci Insiders Placed Bullish Bets Worth US$1.22m", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Absci Corp (ABSI) director Menelas Pangalos adds 37,453 shares in open-market buy", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNWUtYSkNqdWw1NGluMzNaUHpqQ1VIbWVnSjlLZjhLMjRIR3hZN0plWTFqdDBUaTZGTlpXTDNJYzk2dnBRN0tYdzdGb0c0Sl9aY21QanREdnFaY2luRXJUcTBTUkctaER5b0MwWGtPdU9qTkxkNWcyNmVqeVdMMVBHYXVMcHBmN3MyX3dydUR5elpPRmJGNmo4TllEUThLamFMbUk4dGkwdw?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Absci (ABSI) posts Q1 2026 results, advances ABS-201 and adds ABS-202", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOQXJJSmd4Rjg0WkswV0FjdG5jNHBWQVRvOThLYzNtcHl6YmtwczB6MGYxa0RWRDNPcGRLWk81Ty1Cbkd2ZVhvOENaMnBsbVJZV29rLXZyX0pWRWwyeXRJWjVlZ0Q3VXRMNm9YanNUZ1dsXzkwQjh3dVRnUWRRSXRPczBQaWlmbVhFZ29zQW9xekdlN0VwWmVkbnJOQS1KcTRk?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings call transcript: Absci\u2019s Q1 2026 revenue falls short, stock dips", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOYVl6ZW1Id0QxZVhLNXhhRjNSUkhUbmZ3VFhpYW5CbTRfb3pBNVVHcEdFdzNJUTlnVHNsX1oxTFlhVEtNZFg0eW9PcThfazNKdFlUUThBUzA1cVRPWVNOaEVWWEtRQUFWU0Zsd3IxLU5CX3ppaHloVlRLS1ZXeHYzLUZ6ZFp1bDhDR1cxZnBJM3FTYUVHLWREME51RDV1Wjlsd05nMC1SS09QY1piY0dGMGRFdjFCNlIzUTFMdngyTUFXeGMw?oc=5", "source_name": "Investing.com", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci Corporation (ABSI) Reports Q1 Loss, Misses Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxOQk8tOTB4bl96d2hUVVpvMGhMQkZCWEU0MTMtY0NXOXU5Qnhnck9RZ0s5VmxRNDRjckRTb0dCbklCN2o1ZkowVVZud1dZUG9rTjd1cGFDOG5OZ0lqNkdVQlNkQVJpTG1fYXZ3bjF1dXpMN2F0LUNMSm1qd3V1YlkyeC1aTUNFN055X05YTUxsLXUtRWhzMTBSdkRvek53eTQ?oc=5", "source_name": "Market source", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here is Why Absci Corp. (ABSI) is One of the Best Biotech Penny Stocks to Buy in 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxOZTdWaGRHX01QUjBLLVhCdGxVQVU4c1Rjd0pZV0JzZTAyZndkdkk0ZFNRRHNsQ2wyejBMQ19GREdZSDVoOUpLcVpwSHY0ZlhXdXByZE43X1AySVlsWHNRN2MzbGt1cy1qNl9MSnZZeXBZZXZHMktrOFA1c1BJTzZXT2FaNm1yUFVFZTZDRzFtR0w5TlR4VUZn?oc=5", "source_name": "Market source", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "We Think Absci (NASDAQ:ABSI) Needs To Drive Business Growth Carefully", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-04T07:00:00+00:00", "published_display": "04 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Absci (NASDAQ:ABSI) Stock Price Down 7.6% - Should You Sell?", "summary": "Absci (NASDAQ:ABSI) shares dropped 7.6% in mid-day trading following a period of mixed analyst sentiment, despite some analysts raising price targets and maintaining buy ratings. The company's recent earnings report showed better-than-expected EPS but significantly missed revenue", "url": "https://www.marketbeat.com/instant-alerts/absci-nasdaqabsi-stock-price-down-76-should-you-sell-2026-07-16/", "source_name": "MarketBeat", "published_at": "2026-07-16T16:41:35", "published_display": "16 Jul 2026 16:41", "sentiment": "negative", "sentiment_pct": 39, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci to Report Business Updates and Second Quarter 2026 Financial and Operating Results on August 11, 2026", "summary": "Absci Corporation, a clinical-stage biopharmaceutical company, announced it will report business updates and financial results for the second quarter of 2026 after market close on Tuesday, August 11, 2026. A conference call and webcast will follow the announcement to discuss deve", "url": "https://www.globenewswire.com/news-release/2026/07/14/3327246/0/en/absci-to-report-business-updates-and-second-quarter-2026-financial-and-operating-results-on-august-11-2026.html", "source_name": "GlobeNewswire", "published_at": "2026-07-15T14:10:35", "published_display": "15 Jul 2026 14:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci to report Q2FY26 results on August 11, 2026", "summary": "Absci Corporation will release its Q2FY26 financial results and host a conference call on August 11, 2026, to discuss its business updates, financial performance, and future outlook. The clinical-stage biopharmaceutical company, which utilizes generative AI for drug design, is ad", "url": "https://scanx.trade/stock-market-news/companies/absci-to-report-q2fy26-results-on-august-11-2026/45615232", "source_name": "scanx.trade", "published_at": "2026-07-14T23:12:06", "published_display": "14 Jul 2026 23:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci sets 4:30 p.m. ET webcast for its Aug. 11 Q2 update", "summary": "Absci (Nasdaq: ABSI) will report its second quarter 2026 financial and operating results on Tuesday, August 11, 2026, after market close. Management will host a webcasted conference call at 4:30 p.m. Eastern Time to discuss business developments, financial performance, and outloo", "url": "https://www.stocktitan.net/news/ABSI/absci-to-report-business-updates-and-second-quarter-2026-financial-s1qokclg0o80.html", "source_name": "Stock Titan", "published_at": "2026-07-14T20:12:06", "published_display": "14 Jul 2026 20:12", "sentiment": "positive", "sentiment_pct": 59, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wall Street Analysts Predict a 28.3% Upside in ABSCI CORP (ABSI): Here's What You Should Know", "summary": "Wall Street analysts predict a 28.3% upside for Absci Corporation (ABSI), with an average price target of $13.6 and a standard deviation indicating general agreement. While price targets alone are not a reliable investment guide due to potential optimism and business incentives, ", "url": "https://finance.yahoo.com/markets/stocks/articles/wall-street-analysts-predict-28-135502653.html", "source_name": "Market source", "published_at": "2026-07-14T01:16:29", "published_display": "14 Jul 2026 01:16", "sentiment": "positive", "sentiment_pct": 71, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wall Street Zen Downgrades Absci (NASDAQ:ABSI) to Sell", "summary": "Wall Street Zen downgraded Absci (NASDAQ:ABSI) from a \"hold\" to a \"sell\" rating, despite several other analysts recently raising their price targets and maintaining \"buy\" ratings, leading to an overall \"Moderate Buy\" consensus. The downgrade followed Absci's quarterly results, wh", "url": "https://www.marketbeat.com/instant-alerts/wall-street-zen-downgrades-absci-nasdaqabsi-to-sell-2026-07-12/", "source_name": "MarketBeat", "published_at": "2026-07-12T18:39:26", "published_display": "12 Jul 2026 18:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci (ABSI) Morgan Stanley 22nd Annual Global Healthcare Conference Summary", "summary": "Absci (ABSI) discussed its strategic transition from a platform technology company to an AI-driven drug creation firm at the Morgan Stanley 22nd Annual Global Healthcare Conference. The company is now focusing on developing a proprietary pipeline with generative AI for antibody d", "url": "https://quartr.com/events/absci-corporation-absi-morgan-stanley-22nd-annual-global-healthcare-conference_F9f2Jcso", "source_name": "Quartr", "published_at": "2026-07-08T23:39:59", "published_display": "08 Jul 2026 23:39", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci (ABSI) Morgan Stanley 23rd Annual Global Healthcare Conference Summary", "summary": "Absci highlighted its strategic focus on leveraging AI for generative design to tackle challenging drug targets, aiming to reduce development timelines and costs while advancing novel biology. The company discussed its pipeline, including ABS-101 and ABS-201, with key clinical re", "url": "https://quartr.com/events/absci-corporation-absi-morgan-stanley-23rd-annual-global-healthcare-conference_F9f2viKS", "source_name": "Quartr", "published_at": "2026-07-08T11:39:12", "published_display": "08 Jul 2026 11:39", "sentiment": "positive", "sentiment_pct": 77, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci (ABSI) Q4 2024 earnings summary", "summary": "Absci (ABSI) made significant progress in 2024, advancing internal programs and securing new partnerships. Financially, Q4 2024 revenue was $0.7 million, with a full-year revenue of $4.5 million, and the company ended the year with $112.4 million in cash, expected to fund operati", "url": "https://quartr.com/events/absci-corporation-absi-q4-2024_F9f2JrRP", "source_name": "Quartr", "published_at": "2026-07-08T11:39:12", "published_display": "08 Jul 2026 11:39", "sentiment": "positive", "sentiment_pct": 65, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci director Mary T Szela buys $148,866 in stock By Investing.com", "summary": "Absci Corp director Mary T Szela recently purchased 12,900 shares of company common stock for $148,866. This transaction increased her direct ownership to 21,300 shares, occurring while the stock trades near its 52-week high and has seen a 319% return. The company is also advanci", "url": "https://ng.investing.com/news/stock-market-news/absci-director-mary-t-szela-buys-148866-in-stock-93CH-2587530", "source_name": "Investing.com Nigeria", "published_at": "2026-07-07T11:40:29", "published_display": "07 Jul 2026 11:40", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Absci Corp For: 6 July By Investing.com", "summary": "This article from Investing.com reports on a Form 4 filing for Absci Corp (ABSI) dated July 6. The brief piece includes the company's stock symbol and a small negative percentage change for the day, indicating it's a routine financial filing announcement.", "url": "https://ng.investing.com/news/stock-market-news/form-4-absci-corp-for-6-july-93CH-2587542", "source_name": "Investing.com Nigeria", "published_at": "2026-07-07T11:11:07", "published_display": "07 Jul 2026 11:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "H.C. Wainwright Maintains Absci Corp(ABSI.US) With Buy Rating, Maintains Target Price $16", "summary": "H.C. Wainwright has reiterated its Buy rating for Absci Corp (ABSI.US) and maintained a target price of $16. This indicates the firm's continued confidence in the company's future performance.", "url": "https://www.moomoo.com/news/post/72526540/hc-wainwright-maintains-absci-corp-absius-with-buy-rating-maintains", "source_name": "Moomoo", "published_at": "2026-07-06T23:07:43", "published_display": "06 Jul 2026 23:07", "sentiment": "positive", "sentiment_pct": 72, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci (ABSI) director buys 12,900 shares in open-market trade", "summary": "Absci Corp. director Mary T. Szela purchased 12,900 shares of Common Stock at $11.54 per share on June 30, 2026, in an open-market transaction. This transaction increased her direct ownership to 21,300 shares, as detailed in the SEC Form 4 filing. The purchase was executed in acc", "url": "https://www.stocktitan.net/sec-filings/ABSI/form-4-absci-corp-insider-trading-activity-ffd736052e9a.html", "source_name": "Stock Titan", "published_at": "2026-07-06T19:40:25", "published_display": "06 Jul 2026 19:40", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci director Mary T Szela buys $148,866 in stock", "summary": "Absci Corp (NASDAQ:ABSI) director Mary T Szela purchased 12,900 shares of company common stock for $148,866 on June 30, 2026, increasing her direct ownership to 21,300 shares. This insider purchase comes as Absci trades near its 52-week high after a significant 319% return over t", "url": "https://www.investing.com/news/insider-trading-news/absci-director-mary-t-szela-buys-148866-in-stock-93CH-4777404", "source_name": "Investing.com", "published_at": "2026-07-06T16:18:00", "published_display": "06 Jul 2026 16:18", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Absci (ABSI) Undervalued On Encouraging ABS 201 Phase 1 Data?", "summary": "Absci (ABSI) is experiencing strong short-term momentum with its stock up over 221% year-to-date, driven by encouraging interim Phase 1 data for its investigational drug ABS-201 and a recent US$100 million equity offering. While one narrative suggests the company is 6.3% underval", "url": "https://www.sahmcapital.com/news/content/is-absci-absi-undervalued-on-encouraging-abs-201-phase-1-data-2026-07-05", "source_name": "Sahm", "published_at": "2026-07-05T23:10:09", "published_display": "05 Jul 2026 23:10", "sentiment": "positive", "sentiment_pct": 65, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Absci Corporation \u2013 NASDAQ:ABSI", "summary": "This article provides the enterprise value to revenue (forward) for Absci Corporation (NASDAQ: ABSI). It specifies the period, the value, and the percentage change for this financial metric. The information is presented by TradingView, sourcing data from ICE Data Services and Fac", "url": "https://www.tradingview.com/symbols/NASDAQ-ABSI/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-03T11:40:25", "published_display": "03 Jul 2026 11:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Truist Financial Maintains Absci Corp(ABSI.US) With Buy Rating, Raises Target Price to $17", "summary": "Truist Financial has reiterated its \"Buy\" rating for Absci Corp (ABSI.US) and increased its target price to $17. This indicates a positive outlook from the financial institution regarding Absci's stock performance.", "url": "https://news.futunn.com/en/post/75459186/truist-financial-maintains-absci-corp-absius-with-buy-rating-raises", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-07-03T09:40:25", "published_display": "03 Jul 2026 09:40", "sentiment": "positive", "sentiment_pct": 73, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Absci Corporation \u2013 NASDAQ:ABSI", "summary": "This article provides a view of Absci Corporation's (NASDAQ: ABSI) financial data, specifically focusing on its forward price-to-sales ratio. It briefly lists essential financial and market information available on TradingView for the company. The content appears to be a stub or ", "url": "https://www.tradingview.com/symbols/NASDAQ-ABSI/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-03T04:10:41", "published_display": "03 Jul 2026 04:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BTIG Maintains Absci Corp(ABSI.US) With Buy Rating, Maintains Target Price $13", "summary": "BTIG has reiterated its Buy rating for Absci Corp (ABSI.US) and maintained its target price at $13. This indicates a continued positive outlook from the analyst firm regarding the company's stock performance.", "url": "https://news.futunn.com/en/post/75392556/btig-maintains-absci-corp-absius-with-buy-rating-maintains-target", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-07-03T01:10:41", "published_display": "03 Jul 2026 01:10", "sentiment": "positive", "sentiment_pct": 77, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ABSI Maintained by Truist Securities -- Price Target Raised to $17.00", "summary": "Truist Securities has maintained a Buy rating for Absci (ABSI) and increased its price target from $11.00 to $17.00, indicating a bullish outlook. Despite this, GuruFocus assesses ABSI as significantly overvalued by 527.4% with a GF Value of $1.77 against its current price of $11", "url": "https://www.gurufocus.com/news/8943086/absi-maintained-by-truist-securities-price-target-raised-to-1700?mobile=true%3Fmobile%3Dtrue", "source_name": "GuruFocus", "published_at": "2026-07-02T18:09:26", "published_display": "02 Jul 2026 18:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci (ABSI) Is Up 10.3% After Positive ABS-201 Phase 1 Data And $100M Equity Raise", "summary": "Absci Corporation's stock (ABSI) rose 10.3% following positive interim Phase 1 data for its ABS-201 drug, which targets androgenetic alopecia, demonstrating favorable safety and a long half-life. Concurrently, the company completed a $100 million equity offering, providing capita", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-absi/absci/news/absci-absi-is-up-103-after-positive-abs-201-phase-1-data-and", "source_name": "Simply Wall Street", "published_at": "2026-07-02T14:09:26", "published_display": "02 Jul 2026 14:09", "sentiment": "positive", "sentiment_pct": 76, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why Absci Corporation (ABSI) is a Great Momentum Stock to Buy", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNb0RMbTZIa2pneFdnRGNDRWZ5dW1NRWItODZucm5acHo4VkVhT0UxNmlLQzZPTmxqbXB4UnowejBvZEVmWGp2X0J1RmZBNDFqY1VQdzEtLWFPeUlWSnBJQlI1c0RfQmRsTWRNRjVQYlZUY1JwR0lvb3h4UmM2dktsMWlFSHJxS3phZUdGM1NVYzFncWpiYUppcWRUMVNhdw?oc=5", "source_name": "Market source", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Absci Corporation \u2013 NASDAQ:ABSI", "summary": "This article provides access to the enterprise value to EBITDA forward metric for Absci Corporation (NASDAQ:ABSI) through TradingView. It indicates that the market for ABSI was closed at the time of viewing, with no trades mentioned. The content primarily focuses on navigation an", "url": "https://www.tradingview.com/symbols/NASDAQ-ABSI/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-07-01T17:39:59", "published_display": "01 Jul 2026 17:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Absci Corporation \u2013 NASDAQ:ABSI", "summary": "This article provides price-to-earnings forward data for Absci Corporation (NASDAQ: ABSI). It presents a table showing the period, value, and change percentage for this financial metric. The content is hosted on TradingView, indicating that it is a financial data point for invest", "url": "https://www.tradingview.com/symbols/NASDAQ-ABSI/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-30T20:10:42", "published_display": "30 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci Corporation Actuals & Estimates (NASDAQ:ABSI)", "summary": "This article provides an overview of Absci Corporation (NASDAQ: ABSI) stock performance, financial actuals, and analyst estimates. It highlights recent stock price movements, market capitalization, future price forecasts, and key financial metrics including earnings, revenue, and", "url": "https://www.tradingview.com/symbols/NASDAQ-ABSI/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-29T17:09:36", "published_display": "29 Jun 2026 17:09", "sentiment": "positive", "sentiment_pct": 71, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci Stock (ABSI) Opinions on Positive Phase 1 Data for ABS-201", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOdl82ZUl1UkRWUTNPQnNIZlZTY2FPWWtSVEVUazB3STdIMGlRdnF6bHotejVDZTVjMUJDY0s2TG1HeUFWM0ZORGlhdnVINWR0MG4tZUpyV2dhRDcyYWswZFBSMGoyMTF4cXRrTHJYeEx1NjIyRnpheFFieTFBeXNLS3dybEQ4Y1E4VFR5R3NOenpfSTN5MEl6U3dib1M?oc=5", "source_name": "Moomoo", "published_at": "2026-06-28T17:32:53+00:00", "published_display": "28 Jun 2026 17:32", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci Raises $100 Million In Equity To Fund AI-Designed Hair Loss And Endometriosis Program", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/absci-raises-100-million-equity-100125058.html", "source_name": "Benzinga", "published_at": "2026-06-27T10:01:25+00:00", "published_display": "27 Jun 2026 10:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lilly-backed Absci banks $100m to progress endometriosis, hair loss therapy", "summary": "", "url": "https://finance.yahoo.com/m/b1b53458-aba2-319a-9580-7855461fcb65/lilly-backed-absci-banks.html", "source_name": "Pharmaceutical Technology", "published_at": "2026-06-26T10:27:16+00:00", "published_display": "26 Jun 2026 10:27", "sentiment": "negative", "sentiment_pct": 42, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci (ABSI) Is Up 37.8% After ABS-201 Data And Equity Raise - Has The Bull Case Changed?", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/absci-absi-37-8-abs-080654598.html", "source_name": "Simply Wall St.", "published_at": "2026-06-26T08:06:54+00:00", "published_display": "26 Jun 2026 08:06", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ABSCI CORP (ABSI) Soars 36.0%: Is Further Upside Left in the Stock?", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxPQTA5VGNEQ1A2dXRvWVh0VGxadkx2eDV2bG9VeExQaFhuMzNwREFOcnhYRmZaQUEzQVRtbXZ1UHdFMUxBZFB5Tm1ra2RTbWZJTFduWjN6cTVDX2RqdWJ0RGRNSlM0RHZqTWRJNEM2Y1FGMlhxWEdCd2VITFR2dE90MTdIUk9CREc4OVhWbV8wSVpjd1E?oc=5", "source_name": "Market source", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "United States - Goodwin Guides Absci On Pricing Of $100 Million Underwritten Offering", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNbF8wWkY2OGV5aGRnT2t1V2xuN1BhUjFIc0ZybHZHNl96amdnblVLSl9Jdy1falpBOUZJaWJ2eXJMaWJxR1BKeGdHTGxzN3FiMnFUNm5YZU52S3JCQ0NXcW5rS2RRdFBfSE5FNGFtWFJjSHNjUm9qWmNFLW00RkFCdkRKTTIzVEc1azhXc2JqQV9jRGdVQWJhNTRuZkM3TDAxM19KcE1DQ1NlWmVnU2JKTV9IZ2U?oc=5", "source_name": "Mondaq", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci raises $100M as Lilly joins investors backing AI drug program", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxOZmhkb2tPNFpfS0x1QU1wUnl1eWNhMUhBcHpQV2lSVDNvb0RqZkVCTjBzZ3k5Wnc0MG45ZG0zTmFwbHBFS2ZtblFUblBvMkxiSmE3SWQ3Wjdha1YtWXhGMGY1V1h5amdnNGZiRzd3TlJLRHJ0bHJ2SWxfa3hKUlBYRGkwU1lZWkhBTXI3b0FkZkg4bDRIelRzMmNCRC1lV1BMRGdld0pPVXlSMHNUYlBCRjBIYnRiMFpLNEJwVw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci, FuelCell Energy surge premarket; Cerebras, FedEx tumble", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxPMk1rWWFqSnQycTNvQjZmTVBJR0RXZHFEdGhCUWJjN1ZuQlVnSDVWSkxfWG9CeWNiOHMxblFkU0dtWS1vYURPd3B5WTFMWHF5a19xVXhMOE55WEVCSEpZX0Z1Ym9raTdfZXZMOFU4RVlMOUNpZl91UWVvVzBld0I3cW9ZUVJmNVBpMlRKT3NFLV9ucWxhSnNLY2lZY0lkNEtwYWRUUVk0aURqTFdKVklVdWdMcmg4Zkk?oc=5", "source_name": "Investing.com", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci (ABSI) Stock Rallies As Wall Street Boosts Targets", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTFBfRS1uanRBYU9PREw5TjFmQjFIMDZhX1Z3aHJZYlFfbzFyVHBaVDNacXZRTlFIVkdMZEthRm5pczc2QkZhWlAyT2h0d08xUUxGVEJkaUxCODBfMG1aVlM0TkVIelFKRDJJS3NHd1JZSURoRXdqT2RReQ?oc=5", "source_name": "timothysykes.com", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci (NASDAQ: ABSI) prices $100M underwritten equity deal to fund ABS-201", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxQanBZOUJRaF9fZUxhN2JLTTE3dVZyOE5yNmdzek1FSm1fYV9OQUJGcUxtSlRkSlB2UVNzNFhsMHVBNDQxYU1Pb253M1lEaGNvWk02b2syRDktUXJvd1ZZZ2x0YzFrYWJQX3NobjljVFF5M1NVRHFjY1BXT084T1NHeTlpb0U4TFJRQVFiU2JEWTZValFzWDYxbVBWLWg2eXgy?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 424B5 Absci Corp For: 24 June By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxOY3RmdGJfbXZiZkhpS09GQUNlUEZJOUpVRmF2bTlTRmlKSEtOcTVlV3hJRVBMY0JDbVhlOWN2XzJJOS1VS3lZRlRDM3RVbHFUVHV4bzRlUWtvWkVVbXhzX0lpWklyV3QySmc0VVYzV0lYcmo5TmNxVmJMQUdEc2g3QVRKdlpwTjBBSGdqRjQwRVRYVjdSUTRMaGJn?oc=5", "source_name": "Investing.com Canada", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci\u2019s ABS-201 shows 65-day half-life in alopecia trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxNbkNRRWtkN3Y5Y3BWZGh5NGZjZzA2eFJlSHMwR09JLUhiLS1ZcEtzLTZ0U1JURG9YQ0dzcWFTa1E5M3VOc1V6V2l1N3BMY3R4YkMwOUpvcHgyVGttY3NrRkxhUUJYTkdvTHBYWlJ4TmVSQjBjOUVGSF84MG1LQVRtbFJUYTJST3JSSm5SZjJjVDNvd25aQUVqX05paVRYVjRuTzkwNFVPVUpyZDlVR3dIc0IwZ2R1MGI0azN3Rg?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci Shares Soar After Positive Early Clinical Results for Hair Loss Therapy (ABSI)", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNZDRiX1R1V04wSkNRaFUyc19lM2VmN2FrS0JPV1dwWnZkSlBCc1R5Q2hNSXRUWXQ4ZFk5VXR0Q2s4MURYanN2dERZTHVsOWIta1E5VEVJZHhjQkQ4cWFIaURlQ1JxRTRjRHZzZi13cDFnZXVPTS1BaWhWTVBqUFBSZUhQUlFMMi1lb2V0SThXUk9GVWJMT0JMbw?oc=5", "source_name": "Market source", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci rises after early-stage trial data for hair loss therapy and $100M stock offering", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxOczRlX3prd1EwTmYyR0JtY0g3TXhDUHpFUUp2VFlOT1NxMGt3SW5zdXdKb0FHbkVyZkFsNlZ4VHB3ektQc1ZjTFBsUFFnZzNqelFHRWZ2T2JfdkhRWS1YUm5yQnJxdzl0bXhyUWNEandmdmtSV1lfU3ZOUEVDeF9GRGJyZXhNOEQ5eXBHXy1HNzF1OHc?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guggenheim is Bullish on Absci Corporation (ABSI)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxOLUVHcXhrRFNWY2poS2pobnlzeHhTdmNWVUYzTzRoNGhGd1Nuc2M5cy1aZ3RFczFTTEN2cUFmWFRucmZqZ09RbVJ4QnkwaUxrMmdVQktpU1Y4UjdIQlotYW1ual9mMUYxbUhOU0tWaEFUSUJOQXI2NXFLWHQzM2lmQjV5TFViNkRMY2x1ZUJRS0RmQjczTmRPdzdoMVFNc1NfdW9uTw?oc=5", "source_name": "Market source", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci Corp stock hits 52-week high at 8.18 USD", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxQSkRfckVsSUlXakNuU1FteFNWc2RIRzM0ZWxXMXQwck5aRnNWdUV1NFN3YlhLRW1qNnM1Y1RDbXA2MHl1SXl5YzJDUThSc0lRY2tvODgzSWswZVhPYzlTV181UGNXMGxwbFNmWGFfcElhdk5LeWc5RGNhX3VvaVE5LVBReFdRbDVPQ2RHQURlNDdNR0RxN3gtOTN0NnBLc25uZzQ0?oc=5", "source_name": "Investing.com", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Absci Corporation (ABSI) A Good Stock To Buy Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNU1p4bXRNWHFyUzFDM21IUy12TGVFTXNRdW5uR2huTHd2NG9kOWdYSkJYZk5CXzJqNFdHdEpqTW1PdHgwcHJnLWNmZ3h1c3ctbWNfZ2huYjh0ZnVFY1k2ZmdaZHF6alRsLVd3bjRkTklMcmlONGFZSXN1bHFJcXdRdGp1akRXNlphZTNqNjRsQnR3c1ZHNTQ5ZjE1bzQwaUU?oc=5", "source_name": "Market source", "published_at": "2026-06-21T07:00:00+00:00", "published_display": "21 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guggenheim raises Absci stock price target to $15 on hair loss drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNNlZEcjRBWUtabFUweW84dFdyY2Z2OHkxMHVyUW5hZUhrbFFJZUE2S0I2MnFOZVFnNTkxLTFHLXFXeURtbjlrTXM5UDk3N21sZ095bXNUa2xxQWJHV2ptbTFnMVlrWm9CWjNCWDN5a0E0V0NXYnJyZnhWcTZEODYtTGNTSENJMk1DSnNYc2J0SUl0aDVCZFNENC1sN1Y2V1N4OHJ2cTlFYVViMXVxRkE0UjFTcjV2UGZkR2NmdktxVWM5Rlcy?oc=5", "source_name": "Investing.com", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci Corp (ABSI) awards RSUs and stock options to director Szela", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOX1M1b2o3MnRTRXloUkEtcEQzX3Ezal8wTEN0N19nQTd1QldxVkVSZnV5V29xaExnTFdEMXFxMU5KSzkwTER3LUJFZ2hpdkYxVmVfRG5GV2c3WnpFS0FIVTd2OG0xODBPcDV2UWhucDlCV2RNZ1ZGT0p3MDFYUGJTbkV2SmhuWENVT2xOYWZFSmVYTnpSMDMyelg3WjJFaWtJRTQ1SFlOZmZfMWFoZFhyNm5zdjk?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci Corp stock hits 52-week high at 7.44 USD", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPbkdVa21lZWJaVk82My1IbDliT1J5QWN5dDZUUkZBUWFRa0ZEcjdQVmZ2cDJuc1czZVhYNjNmMEk2TlpSQkMyQlA4T010cGNIWWItSFp4cGVjQTMxZnFSZF9nNUVjWGNLclpOSHFvTjVxUkxIam1ObGozNkp6Y1NNVms3SU51MG1QR29rcEVOcUt1eDZGNkN2U242RFZLOTJtRWZz?oc=5", "source_name": "Investing.com", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci Insiders Placed Bullish Bets Worth US$1.22m", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci Corp (ABSI) director Menelas Pangalos adds 37,453 shares in open-market buy", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNWUtYSkNqdWw1NGluMzNaUHpqQ1VIbWVnSjlLZjhLMjRIR3hZN0plWTFqdDBUaTZGTlpXTDNJYzk2dnBRN0tYdzdGb0c0Sl9aY21QanREdnFaY2luRXJUcTBTUkctaER5b0MwWGtPdU9qTkxkNWcyNmVqeVdMMVBHYXVMcHBmN3MyX3dydUR5elpPRmJGNmo4TllEUThLamFMbUk4dGkwdw?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci (ABSI) posts Q1 2026 results, advances ABS-201 and adds ABS-202", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOQXJJSmd4Rjg0WkswV0FjdG5jNHBWQVRvOThLYzNtcHl6YmtwczB6MGYxa0RWRDNPcGRLWk81Ty1Cbkd2ZVhvOENaMnBsbVJZV29rLXZyX0pWRWwyeXRJWjVlZ0Q3VXRMNm9YanNUZ1dsXzkwQjh3dVRnUWRRSXRPczBQaWlmbVhFZ29zQW9xekdlN0VwWmVkbnJOQS1KcTRk?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings call transcript: Absci\u2019s Q1 2026 revenue falls short, stock dips", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOYVl6ZW1Id0QxZVhLNXhhRjNSUkhUbmZ3VFhpYW5CbTRfb3pBNVVHcEdFdzNJUTlnVHNsX1oxTFlhVEtNZFg0eW9PcThfazNKdFlUUThBUzA1cVRPWVNOaEVWWEtRQUFWU0Zsd3IxLU5CX3ppaHloVlRLS1ZXeHYzLUZ6ZFp1bDhDR1cxZnBJM3FTYUVHLWREME51RDV1Wjlsd05nMC1SS09QY1piY0dGMGRFdjFCNlIzUTFMdngyTUFXeGMw?oc=5", "source_name": "Investing.com", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Absci Corporation (ABSI) Reports Q1 Loss, Misses Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxOQk8tOTB4bl96d2hUVVpvMGhMQkZCWEU0MTMtY0NXOXU5Qnhnck9RZ0s5VmxRNDRjckRTb0dCbklCN2o1ZkowVVZud1dZUG9rTjd1cGFDOG5OZ0lqNkdVQlNkQVJpTG1fYXZ3bjF1dXpMN2F0LUNMSm1qd3V1YlkyeC1aTUNFN055X05YTUxsLXUtRWhzMTBSdkRvek53eTQ?oc=5", "source_name": "Market source", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here is Why Absci Corp. (ABSI) is One of the Best Biotech Penny Stocks to Buy in 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxOZTdWaGRHX01QUjBLLVhCdGxVQVU4c1Rjd0pZV0JzZTAyZndkdkk0ZFNRRHNsQ2wyejBMQ19GREdZSDVoOUpLcVpwSHY0ZlhXdXByZE43X1AySVlsWHNRN2MzbGt1cy1qNl9MSnZZeXBZZXZHMktrOFA1c1BJTzZXT2FaNm1yUFVFZTZDRzFtR0w5TlR4VUZn?oc=5", "source_name": "Market source", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We Think Absci (NASDAQ:ABSI) Needs To Drive Business Growth Carefully", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-04T07:00:00+00:00", "published_display": "04 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 99, "total_relevant": 62, "sentiment_summary": {"positive": 28, "negative": 6, "neutral": 28, "score": 58, "total": 62, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 79, "events": [{"event": "general", "label": "Market update", "weight": 18.5, "count": 33}, {"event": "earnings", "label": "Earnings", "weight": 9.9, "count": 20}, {"event": "analyst", "label": "Analyst action", "weight": 3.85, "count": 7}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}], "positive_events": 28, "negative_events": 6}, "market_context": {"has_market_context": true, "latest_close": 10.6, "latest_week": "2026-07-10", "one_week_move": -8.8, "four_week_move": 55.9, "twelve_week_move": 196.1, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.492375, "market_dynamics_buy_signal": false, "relative_strength": 133.432545, "fair_value_gap": 195.9, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 54.5721, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-8.8% over one week, +55.9% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 67, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 14}, {"label": "Stock Titan", "count": 8}, {"label": "Investing.com", "count": 6}, {"label": "TradingView", "count": 5}, {"label": "simplywall.st", "count": 4}, {"label": "Quartr", "count": 3}, {"label": "MarketBeat", "count": 2}, {"label": "Investing.com Nigeria", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 54}, {"label": "Industry context", "count": 8}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 33}, {"label": "Earnings", "count": 20}, {"label": "Analyst action", "count": 7}, {"label": "Regulatory and legal", "count": 1}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "58/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "79/100 classification confidence."}, {"label": "Company focus", "value": "54", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-8.8% over one week, +55.9% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Negative", "tone": "negative", "text": "Absci (NASDAQ:ABSI) Stock Price Down 7.6% - Should You Sell?"}], "updated_at": "2026-07-18T06:14:12.489251+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}